
Kevin Haigis Lab
@kevinhaigislab
Integrating Cancer Biology and Systems Biology to Identify New Therapeutic Opportunities, focusing on the RAS oncoproteins.
ID: 1034571611662376960
http://www.haigislab.org 28-08-2018 22:41:08
229 Tweet
1,1K Followers
259 Following

Deadline Extended! There's just one more week to secure discounted registration & submit an abstract for talk consideration at #AMC23. With an incredible speaker line up, this is not one to miss! 📆Talk submission: 03 Mar 2023 🌐fusion-conferences.com/conference/147 Kevin Haigis Lab Julien Sage


🌟At #AACRras23: Kevin Haigis Lab speaks about K-RAS hyperexchange mutants in colorectal cancer. See his Review article published in Cancer Discovery last year: Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention 👇 aacrjournals.org/cancerdiscover…

🌟🌟🌟Kevin Haigis Lab speaks today at #AACRras23. Find his review about Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention published last year in Cancer Discovery for the 40 years anniversary 👇 aacrjournals.org/cancerdiscover…


Register today for Dana-Farber’s CSO Forum on 3/28 to learn how scientific collaborations with researchers and physicians worldwide help advance revolutionary science and extraordinary care for patients with cancer. Sign-up today for this virtual event: dfci.zoom.us/webinar/regist…


We are recruiting a research tech with some experience in handling a mouse colony. Location: MSKCC, Manhattan. Competitive pay and benefits. Email: [email protected] if interested. Please RT


What's to blame for certain cancer outcomes? A pair of studies shows the Y chromosome plays a key role in colon and bladder cancers. Dana-Farber's Chief Scientific Officer Kevin Haigis (Kevin Haigis Lab) talks with USA TODAY about the findings: usatoday.com/story/news/hea…

Check out the Cancer Discovery papers highlighted in the new AACR Journals collection, Targeting KRAS. bit.ly/435Ncvm Norbert Kraut Kevin Haigis Lab Anna Farago, MD, PhD



Kevin Haigis Lab opening remarks for the first Fusion conference Fusion Conferences on animal models of cancer #AMC23



Next up, our very own conference chair Kevin Haigis Lab takes the stage with a talk on TISSUE-SPECIFIC ONCOGENICITY OF K-RAS #AMC23


A special thank you to Clint Stalnecker and Channing Der Der Lab at UNC for writing an excellent preview for our Molecular Cell paper out this week. cell.com/molecular-cell…


From the newest issue— Allosteric Regulation of Switch-II Domain Controls #KRAS Oncogenicity, by Simanshu Dhirendra, @FredNatLab, Kevin Haigis Lab et al. bit.ly/3SbUOuB Dana-Farber News



In Cancer Epidemiology, Biomarkers & Prevention Effects of KRAS genetic interactions on outcomes in #LungCancer, #PancreaticCancer & #ColorectalCancer aacrjournals.org/cebp/article-a… Mining the massive AACR GENIE database, this study identifies the prognostic impact of KRAS mutations on survival (across all three

Hard launch! First week as a #NewPI Dana-Farber 👩🔬 Interested in molecular imaging, chemistry or radiobiology? Postdoc and research tech positions to follow soon! Eternally grateful to Kevin Haigis Lab and the lab for their support over the last 3.5 years 🧬🧫🧪☢️⭐️🔬


Congrats Kevin Haigis, PhD, Dana-Farber's Chief Scientific Officer - recognized as a Fellow of the American Association for the Advancement of Science (AAAS) for distinguished contributions within biological sciences. Kevin Haigis Lab Press release: ms.spr.ly/6019Y6Whf

